CCL4 and Hepatic fibrosis: Reminiscent to our study, iNKT cells require NKG2D surface expression to inhibit liver fibrosis after IL-30 treatment by selectively removing CCL4-activated hepatic stellae cells through an NKG2D/RAE-1interaction.